Retratrutide 30mg

Description

Retatrutide 30 mg is a next-generation investigational peptide developed to engage multiple metabolic pathways. As a triple agonist interacting with GLP-1, GIP, and glucagon receptors, it is recognised for its relevance within metabolic and endocrine research contexts. Vital Peptides’ Retatrutide is produced to research-grade standards, with independently verified purity and consistency to support controlled experimental use.

Key Features

• Produced under rigorous quality control protocols to ensure consistency and purity
• Triple receptor agonist designed for multi-pathway metabolic research applications
• Lyophilised formulation to support stability and reliable long-term storage

Applications

• Use in research models examining metabolic regulation and energy balance
• Multi-pathway approaches to glucose and insulin-related research
• Investigations involving lipid metabolism and cardiovascular-associated pathways

Specifications and Documentation

• Material Safety Data Sheet (MSDS): Coming Soon
• Handling and Storage Instructions: Coming Soon

Additional Information

Retatrutide 30 mg offers researchers a versatile investigational compound within the evolving field of metabolic science. Its multi-receptor activity and high-purity formulation make it a valuable tool for laboratories examining complex metabolic and regulatory pathways.